---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-022024"
form_type: "8-K"
ticker: "CLDI"
cik: "0001855485"
company_name: "Calidi Biotherapeutics, Inc."
filed_at: "2026-05-08T23:59:59+00:00"
generated_at: "2026-05-14T21:10:39.390446+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Calidi Biotherapeutics issues warrant for 17.4M shares at $0.23 in private placement

## Summary
- Warrant to purchase up to 17,391,304 shares of common stock at $0.23 per share issued to accredited investor.
- Warrant first exercisable on September 8, 2026; vesting tied to future registered issuances of up to $4.0M.
- Registered issuances may occur before July 8, 2026 but neither party is obligated to complete them.
- Issuance exempt under Section 4(a)(2) and Rule 506(b) based on investor's accredited status.
- Shares issuable upon exercise are restricted; no registration statement filed for resale.

## SEC filing metadata
- accession: 0001493152-26-022024
- form_type: 8-K
- ticker: CLDI
- cik: 0001855485
- company_name: Calidi Biotherapeutics, Inc.
- filed_at: 2026-05-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855485/000149315226022024/0001493152-26-022024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855485/000149315226022024/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-022024
- JSON: https://secwatch.observer/filing/0001493152-26-022024.json
- Plain text: https://secwatch.observer/filing/0001493152-26-022024.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.